The bizarre world of drug pricing

Forbes

19 November 2018 - There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. 

Then there is the Trump administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by implementing an international pricing index. These policies, if implemented, would harm the quality of health care in the U.S. by reducing patients’ access to medicines and harming future innovations.

What’s worse, the policies are chasing the wrong rabbit; rising pharmaceutical prices are not driving the current health care affordability problem. Consider the pricing data as reflected in the consumer price index measure of inflation.

Read Forbes article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing , Comparison